Cargando…
Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
At present, concerns that the recent global emergence of SARS-CoV-2 variants could compromise the current vaccines have been raised, highlighting the urgent demand for new vaccines capable of eliciting T cell-mediated immune responses, as well as B cell-mediated neutralizing antibody production. In...
Autores principales: | Kim, Byoung-Jun, Jeong, Hyein, Seo, Hyejun, Lee, Mi-Hyun, Shin, Hyun Mu, Kim, Bum-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432291/ https://www.ncbi.nlm.nih.gov/pubmed/34512635 http://dx.doi.org/10.3389/fimmu.2021.712274 |
Ejemplares similares
-
Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection
por: Kim, Byoung-Jun, et al.
Publicado: (2019) -
Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
por: Lee, Mi-Hyun, et al.
Publicado: (2023) -
A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation
por: Jeong, Hyein, et al.
Publicado: (2021) -
Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
por: Chiok, Kim R., et al.
Publicado: (2023) -
Predicting Epitope Candidates for SARS-CoV-2
por: Agarwal, Akshay, et al.
Publicado: (2022)